Position in LH
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$22,566,320
+$1,810,637 QoQ
Shares Held
80,594
+3.6% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#106
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $185,901,822 across 25 Diagnostics & Research names. LH ranks #5 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
197,012 | $38,066,658 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
66,520 | $33,350,467 | |
| 3 | A |
Agilent Technologies, Inc.
|
214,808 | $28,532,946 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
46,428 | $24,441,556 | |
| 5 | LH |
Labcorp Holdings Inc.
This page
|
80,594 | $22,566,320 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
61,463 | $13,939,193 | |
| 7 | DHR |
Danaher Corp /De/
|
46,092 | $8,779,604 | |
| 8 | NTRA |
Natera, Inc.
|
18,343 | $4,979,207 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,566,320 | 80,594 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $20,755,683 | 77,792 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $17,906,058 | 71,373 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $19,816,325 | 69,032 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $18,448,940 | 70,279 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $13,557,337 | 58,251 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $13,115,269 | 57,192 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $11,224,059 | 50,224 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $10,631,158 | 52,239 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||